StonvexLoading…
StonvexStonvexStonvexCore line items from DRCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.68M | $34.69M | $26.29M | $18.30M |
Operating Income | $-3.25M | $-14.76M | $-10.26M | $-6.35M |
Net Income | $-5.25M | $-18.95M | $-7.28M | $-4.60M |
EPS (Diluted) | $-10.32 | $-75.79 | $-0.78 | $-0.55 |
Total Assets | $19.26M | $20.16M | $22.54M | $23.33M |
Total Liabilities | $28.98M | $27.18M | $29.23M | $47.91M |
Cash & Equivalents | $796.00K | $728.00K | $871.00K | $1.59M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 575.00K | 308.00K | 9.86M | 8.32M |